<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04886037</url>
  </required_header>
  <id_info>
    <org_study_id>endo-sestrin</org_study_id>
    <nct_id>NCT04886037</nct_id>
  </id_info>
  <brief_title>Evaluation of Sestrin Levels in Patients With Endometriosis</brief_title>
  <official_title>The Sestrin Levels in Patients With Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Serum sestrin levels of endometriosis patients are compared with a group of healthy&#xD;
      volunteers of the same age.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serum sestrin levels are compared with 45 endometriosis patients and 45 healthy volunteers of&#xD;
      the same age. The energy metabolism of the endometriosis group and its possible relationship&#xD;
      with the endometriosis stage will be compared since sestrin gives information about the&#xD;
      energy metabolism of the people.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">July 20, 2021</completion_date>
  <primary_completion_date type="Actual">July 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum sestrin levels in women with endometriosis</measure>
    <time_frame>6 months</time_frame>
    <description>Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of the relationship between serum sestrin level and endometriosis stage</measure>
    <time_frame>6 months</time_frame>
    <description>By comparing the relation of serum sestrin level with the stage of endometriosis, its relation with serum level in patients with advanced and early stage endometriosis will be examined. The possible effect of sestrin on disease pathogenesis will be examined.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>women with endometriosis</arm_group_label>
    <description>It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>It consists of healty women between the ages of 18-45</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sestrin</intervention_name>
    <description>Serum sestrin levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group.</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>women with endometriosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The serum sestrin level of women between the ages of 18-45 who have been diagnosed with&#xD;
        endometriosis by surgery or ultrasound will be compared with the level of women of the same&#xD;
        age.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosed with endometriosis (Surgery or ultrasound)&#xD;
&#xD;
          -  Women without endometriosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women without endometriosis&#xD;
&#xD;
          -  women who are only suspected endometriosis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pinar Yalcin Bahat</name>
      <address>
        <city>Istanbul</city>
        <state>İ̇stanbul</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 9, 2021</study_first_submitted>
  <study_first_submitted_qc>May 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Yalcin bahat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>sestrin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

